FuturedMe is seeking collaborative research and partnering with pharmaceutical companies and academic clinicians who aim to tackle targets that are difficult to design using conventional drug discovery methods, in anticipation of the next NEDO-DTSU PCA phase. Those interested in creating new therapeutic options using CANDDY technology are welcome to contact us at admin@futuredme.com.